Cargando…
Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis
Glatiramer acetate (GA) represents one of the most common disease-modifying therapies for multiple sclerosis. GA is currently approved for patients at high risk of developing clinically definite multiple sclerosis (CDMS) after having experienced a well-defined first clinical episode (clinically isol...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Libertas Academica
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619555/ https://www.ncbi.nlm.nih.gov/pubmed/23650472 http://dx.doi.org/10.4137/JCNSD.S8755 |